VENUSREM.NS

Venus Remedies Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,739.10

+2.12%Jun 19, 2026

AI Brief

Market cap

$22.73B

52w range

—

P / E

—

EPS · FY 2026

$76.89

Volume

—

Revenue · FY 2026

$7.7B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Venus Remedies Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1739.10

Change

+305.76%

Period high

$1883.00

Period low

$428.60

Period start

$428.602025-06-24

Through 2026-06-19

Fair value

Football field →

Weighted blend

$1,722.40

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

VENUSREM.NS

1,739+305.76%

H 1,944L 416.00MA50 1,205MA200 791.90Avg vol 60K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.01%
Consumer Cyclical
+0.94%
Energy
+0.84%
Consumer Defensive
+0.82%
Financial Services
+0.23%
Basic Materials
-0.11%
Healthcare
-0.18%
Communication Services
-0.18%
Industrials
-0.47%
Technology
-0.85%
Utilities
-1.03%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+1.99%
Software - Services
+9.60%
Broadcasting
+8.34%
Travel Services
+7.87%
Computer Hardware
+4.56%
Oil & Gas Energy
-3.54%
Biotechnology
+3.28%
Electrical Equipment & Parts
-3.26%
Semiconductors
-2.12%
Communication Equipment
+2.06%
REIT - Healthcare Facilities
+2.01%
Consulting Services
-1.97%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for VENUSREM.NS.

Financial scores

DBJun 23, 2026

Altman Z

8.87

Safe

≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress

Piotroski F

6/9

Average

≥ 7 strong · 4–6 average · < 4 weak

Peers

No peer list available for VENUSREM.NS.

Total assets

$8.54B

Total debt

$124.1M

Cash & equiv

$306.1M

Operating CF

$1.57B

Free cash flow

$1.2B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$7.7B	$1.22B	$1.03B	$76.89	+13.35%